Fever News and Research

RSS

FDA approves use of abraxane to treat patients with late-stage pancreatic cancer

The U.S. Food and Drug Administration today expanded the approved uses of Abraxane (paclitaxel protein-bound particles for injectable suspension, ablumin-bound) to treat patients with late-stage (metastatic) pancreatic cancer.

7 Sep 2013

FDA grants Priority Review status to Takeda's investigational drug vedolizumab for ulcerative colitis

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States Food and Drug Administration has granted Priority Review status for the Biologics License Application for its new investigational drug vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis.

5 Sep 2013

Sanofi Pasteur reports clinical benefit of Fluzone High-Dose vaccine in preventing influenza

Sanofi Pasteur, the vaccines division of Sanofi, today announced topline results of a large-scale, multi-center efficacy trial in people 65 years of age and older showing a superior clinical benefit of Fluzone High-Dose (Influenza Virus Vaccine) relative to the standard dose of Fluzone vaccine in preventing influenza.

26 Aug 2013

HEALTHY FUTURES project aims to address risk of outbreaks, transmission of VBDs

Important outputs are starting to arise from the HEALTHY FUTURES (Health, environmental change and adaptive capacity) project, which aims to address the risk of outbreaks and transmission of three water-related vector-borne diseases (VBDs) in eastern Africa. HEALTHY FUTURES is now past its halfway point, with less than eighteen months of the project remaining.

26 Aug 2013

Researchers uncover how SARS coronavirus uses host cell to reproduce itself

UC Irvine infectious disease researchers have uncovered components of the SARS coronavirus - which triggered a major outbreak of severe acute respiratory syndrome in 2002-03 - that allow it to take over host cells in order to replicate.

23 Aug 2013

People exposed to hot environments may develop Malignant hyperthermia

There is mounting evidence that some people who are susceptible to Malignant hyperthermia (MH) will develop MH when exposed to hot environments or with exercise.

22 Aug 2013

Risk factors linked to death may be reversible in severe encephalitis patients

People with severe encephalitis - inflammation of the brain - are much more likely to die if they develop severe swelling in the brain, intractable seizures or low blood platelet counts, regardless of the cause of their illness, according to new Johns Hopkins research.

21 Aug 2013

FDA reminds health care providers not to administer any NuVision Pharmacy sterile products to patients

Products may still pose serious risk to patients The U.S. Food and Drug Administration is reminding health care providers about safety concerns with all sterile drug products made and distributed by NuVision Pharmacy of Dallas, Texas.

20 Aug 2013

Study shows superantigens produced by staph bacteria cause infective endocarditis and sepsis

University of Iowa researchers have discovered what causes the lethal effects of staphylococcal infective endocarditis - a serious bacterial infection of heart valves that kills approximately 20,000 Americans each year.

20 Aug 2013

TSRI scientists discover molecular mechanism by which deadly Ebola virus assembles

Scientists at The Scripps Research Institute (TSRI) have discovered the molecular mechanism by which the deadly Ebola virus assembles, providing potential new drug targets.

16 Aug 2013

Scientists uncover potential drug target for effective therapy against bacterial disease brucellosis

UC Davis scientists have uncovered a potential drug target for the development of an effective therapy against the debilitating, chronic form of the bacterial disease brucellosis, which primarily afflicts people in Mediterranean and Middle Eastern countries.

16 Aug 2013

Preventive antibiotics for HIV patients lower risk of TB or death

As part of the largest international research effort ever made to combat tuberculosis, a team of Johns Hopkins and Brazilian experts has found that preventive antibiotic therapy for people with HIV lowers this group's chances of developing TB or dying.

16 Aug 2013

Harvard University receives grant to use organs-on-chips device to test human response to radiation

A team at the Wyss Institute for Biologically Inspired Engineering at Harvard University has received a $5.6 million grant award from the United States Food and Drug Administration (FDA) to use its Organs-on-Chips technology for a novel application of keen interest to national security and health officials: to test human physiological responses to radiation, and to evaluate drugs designed to counter those effects.

13 Aug 2013

Research shows how mammalian and bacterial kingdoms interact

The bacteria Streptococcus pneumoniae harmlessly colonizes the mucous linings of throats and noses in most people, only becoming virulent when they leave those comfortable surroundings and enter the middle ears, lungs or bloodstream. Now, in research published in July in mBio, University at Buffalo researchers reveal how that happens.

8 Aug 2013

TGen receives $20,000 grant from ACF for STEM education

The Translational Genomics Research Institute (TGen) received another boost today for Science, Technology, Engineering and Math (STEM) education with a $20,000 grant from the Arizona Community Foundation (ACF).

7 Aug 2013

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

NanoViricides, Inc. said it has signed a non-disclosure agreement with the Lovelace Respiratory Research Institute. The Company intends to enter into a Master Services Agreement with LRRI for the IND-enabling efficacy studies of both its broad-spectrum injectable and oral FluCide drug candidates.

5 Aug 2013

New research may influence development of anti-viral therapies to fight against Dengue

New research into the fight against Dengue, an insect-borne tropical disease that infects up to 390 million people worldwide annually, may influence the development of anti-viral therapies that are effective against all four types of the virus.

3 Aug 2013

Scientists solve structure of infection tool used by Yersinia bacterium

Abdominal pain, fever, diarrhoea -- these symptoms could point to an infection with the bacterium Yersinia. The bacterium's pathogenic potential is based on a syringe-like injection apparatus called injectisome.

1 Aug 2013

Prevention against EEE and West Nile virus is within everyone's control

Every year reported cases of Eastern Equine Encephalitis and the West Nile virus surface in communities around the country, raising concerns and questions about mosquito borne-illnesses. Despite reports that children and the elderly are at greatest risk, anyone can be stricken by these viruses. But prevention is within everyone's control.

1 Aug 2013

Interferon-free treatment for genotype-1b hepatitis C patients: an interview with Professor Wulf Boecher, Boehringer Ingelheim

Genotype 1 is, worldwide, the most prevalent genotype of the hepatitis C virus. It accounts for around seventy percent of all hepatitis C infections.

30 Jul 2013

Fever News and Research

FDA approves use of abraxane to treat patients with late-stage pancreatic cancer

FDA grants Priority Review status to Takeda's investigational drug vedolizumab for ulcerative colitis

Sanofi Pasteur reports clinical benefit of Fluzone High-Dose vaccine in preventing influenza

HEALTHY FUTURES project aims to address risk of outbreaks, transmission of VBDs

Researchers uncover how SARS coronavirus uses host cell to reproduce itself

People exposed to hot environments may develop Malignant hyperthermia

Risk factors linked to death may be reversible in severe encephalitis patients

FDA reminds health care providers not to administer any NuVision Pharmacy sterile products to patients

Study shows superantigens produced by staph bacteria cause infective endocarditis and sepsis

TSRI scientists discover molecular mechanism by which deadly Ebola virus assembles

Scientists uncover potential drug target for effective therapy against bacterial disease brucellosis

Preventive antibiotics for HIV patients lower risk of TB or death

Harvard University receives grant to use organs-on-chips device to test human response to radiation

Research shows how mammalian and bacterial kingdoms interact

TGen receives $20,000 grant from ACF for STEM education

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

New research may influence development of anti-viral therapies to fight against Dengue

Scientists solve structure of infection tool used by Yersinia bacterium

Prevention against EEE and West Nile virus is within everyone's control

Interferon-free treatment for genotype-1b hepatitis C patients: an interview with Professor Wulf Boecher, Boehringer Ingelheim

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News